Suppr超能文献

脉络膜上腔出血的危险因素和治疗方法。

Risk Factors and Treatments of Suprachoroidal Hemorrhage.

机构信息

The First People's Hospital of Yunnan Province (Kunhua Hospital Affiliated with Kunming University of Science and Technology), Kunming, China.

出版信息

Biomed Res Int. 2022 Jul 14;2022:6539917. doi: 10.1155/2022/6539917. eCollection 2022.

Abstract

Suprachoroidal hemorrhage (SCH) is a rare but serious sight-threatening complication of inner eye surgery. Despite continuous advances in treatment, visual prognosis remains poor. The disease has a more typical clinical presentation, the etiology and pathogenesis are not well defined, and intraoperative ocular and systemic factors may induce fulminant SCH. To investigate risk factors and treatments of SCH-associated intraocular surgeries, summarize diagnosis, characteristics, management, and prevention of SCH developed during and after intraocular surgeries. A retrospective study of SCH occurred in six cases of intraocular surgeries including cataract, glaucoma, pars plana vitrectomy (PPV), and silicone oil removal surgery. Assess baseline systemic and ocular characteristics of SCH eyes. Analyze the second surgery timing and technique, and visual outcomes were measured. SCH occurred in six patients including five eyes during surgeries and one eye after the surgery. Three eyes that underwent cataract surgery had hard nucleuses (nuclear sclerotic 4+). One eye was due to hypotony during the vitrectomy procedure. One eye developed SCH when silicone oil was extracted from the eyeball. One eye developed delayed SCH after glaucoma surgery. Incision closure and anterior chamber deepening were performed. B-scan ultrasonography was used to diagnose SCH, and determine the timing and location of sclerotomy for the second surgery. Vitrectomy and sclerotomy were performed in five eyes. The median follow-up time was six months. The final best-corrected visual acuity (BCVA) was 0.3 in one eye, one eye had light perception with retinal adherence, and four eyes had no light perception with retinal detachment. The results showed that risk factors including advanced age, hypertension, taking anticoagulants, antiplatelet drugs, and cardiovascular drugs were systemic risk factors, and hard nucleus (nuclear sclerosis 4 +) cataract, long-term uncontrolled ocular hypertension glaucoma, vitrectomy, silicone oil removal, high myopia, aphakia, previous intraocular surgery, intraocular pressure during surgery, and others were ocular risk factors. The most important risk factor is a sudden drop in intraocular pressure during or after surgery. The outcome of visual acuity depends on retinal status. Because of the poor prognosis, the prevention of SCH is of utmost importance during intraocular surgery.

摘要

脉络膜上腔出血 (SCH) 是内眼手术后一种罕见但严重的致盲性并发症。尽管治疗方法不断进步,但视力预后仍然不佳。该疾病具有更典型的临床表现,其病因和发病机制尚不清楚,术中眼内和全身因素可能导致暴发性 SCH。为了探讨与眼内手术相关的 SCH 的危险因素和治疗方法,总结了眼内手术后发生的 SCH 的诊断、特点、处理和预防。对 6 例眼内手术(白内障、青光眼、经睫状体平坦部玻璃体切除术(PPV)和硅油取出术)中发生的 SCH 进行回顾性研究。评估 SCH 眼的基础全身和眼部特征。分析第二次手术时机和技术,并测量视力结果。SCH 发生在 6 例患者的 5 只眼中,1 只眼在手术后。3 只接受白内障手术的眼为硬核(核硬化 4+)。1 只眼在玻璃体切割术中发生低眼压。1 只眼在从眼球中提取硅油时发生 SCH。1 只眼在青光眼手术后发生迟发性 SCH。行切口闭合和前房加深术。B 型超声检查用于诊断 SCH,并确定第二次手术的巩膜切口位置和时机。5 只眼行玻璃体切割术和巩膜切开术。中位随访时间为 6 个月。最终最佳矫正视力(BCVA)为 1 只眼 0.3,1 只眼光感伴视网膜贴附,4 只眼无光感伴视网膜脱离。结果表明,包括高龄、高血压、服用抗凝剂、抗血小板药物和心血管药物在内的危险因素为全身危险因素,硬核(核硬化 4+)白内障、长期未控制的高眼压性青光眼、玻璃体切割术、硅油取出术、高度近视、无晶状体眼、既往眼内手术、手术中眼压以及其他因素为眼部危险因素。最重要的危险因素是手术中或手术后眼内压突然下降。视力预后取决于视网膜状态。由于预后较差,眼内手术期间 SCH 的预防至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/9303137/76e6a1977b32/BMRI2022-6539917.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验